Topics

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation:

11:40 EDT 30 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 20/09/2006, Revision: 39, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation:

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation:"

Quick Search

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Human Papillomavirus (HPV)
Human papilloma viruses (HPV) affect the skin and the moist membranes lining your body, for example, in your cervix, anus, mouth and throat. HPV is a common and highly contagious infection, with over three quarters of sexually active women acquiring it ...